# A Study of EDP-297 in Healthy Subjects

> **NCT04559126** · PHASE1 · COMPLETED · sponsor: **Enanta Pharmaceuticals, Inc** · enrollment: 82 (actual)

## Conditions studied

- NASH - Nonalcoholic Steatohepatitis With Liver Fibrosis

## Interventions

- **DRUG:** EDP-297
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04559126
- **Lead sponsor:** Enanta Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-08
- **Primary completion:** 2021-06-21
- **Final completion:** 2021-06-21
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2021-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04559126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04559126, "A Study of EDP-297 in Healthy Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04559126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*